Clinical Trials Browser

INDUSTRY × Interventional × Lasofoxifene × Clear all

Evaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation